Early-Life Exposures and Early-Onset Uterine Leiomyomata in Black Women in the Sister Study by D’Aloisio, Aimee A. et al.
406  v o l u m e  120 | n u m b e r 3 | March 2012  •  Environmental Health Perspectives
Research
Uterine leiomyomata (fibroids) are highly 
prevalent benign tumors (Baird et al. 2003) 
that are the principal indication for hyster-
ectomies in the United States (Farquhar and 
Steiner 2002). Fibroid-related morbidity 
may include pelvic pain, heavy bleeding, and 
reproductive problems (Stewart 2001). Black 
women have an increased risk of developing 
fibroids and greater severity of symptoms than 
do white women (Baird et al. 2003; Faerstein 
et al. 2001; Kjerulff et al. 1996; Marshall et al. 
1997; Wise et al. 2005b). Although fibroids 
may be asymptomatic, prevalence estimates 
based on clinically evident disease have been 
as high as 50% for blacks and 25% for whites 
(Baird et al. 2003; Stewart 2001).
Although it is known that hormones 
influence fibroid development (Marsh and 
Bulun 2006), little is known about the risk 
factors that could explain these hormonal 
mechanisms. One hypothesis is that fibroid 
pathogenesis is influenced by early-life and 
childhood exposures that may affect the 
development of the uterus and later impact 
how a woman responds to hormonal chal-
lenges as an adult (Baird 2004). Proof of prin-
ciple for this hypothesis is based on neonatal 
laboratory rodents exposed to experimental 
diethylstilbestrol (DES). In response to DES 
exposure, expression of estrogen-responsive 
genes was developmentally reprogrammed 
in the neonatal uterus, leading to fibroid 
development after maturity (Greathouse et al. 
2008). Consistent with the laboratory animal 
findings, early data from non-Hispanic white 
participants in the Sister Study showed sug-
gestive evidence of an elevated risk of early-
onset uterine fibroids for women with in utero 
DES exposure (D’Aloisio et al. 2010). Other 
factors associated with early-onset fibroid 
development were having a mother diag-
nosed with diabetes before the index preg-
nancy (leading to participant’s birth), early 
gestational age at birth, having been fed soy 
formula, and low childhood socio  economic 
status (D’Aloisio et al. 2010). At the time of 
our previous analysis, enrollment of the Sister 
Study cohort was ongoing, and we did not 
have sufficient numbers to evaluate associa-
tions with early-life factors for black women. 
With enrollment now complete, we were able 
to evaluate whether early-life and childhood 
exposures were associated with self-reported 
early-onset fibroids using baseline data from 
black participants in the Sister Study and to 
compare these results with associations found 
among non-Hispanic whites from the com-
plete cohort. Our study examined early-life 
factors related to the mother’s index preg-
nancy and participant’s birth and feeding 
during infancy, as well as childhood develop-
mental and socio  economic factors.
Materials and Methods
Study population. The Sister Study [National 
Institute of Environmental Health Sciences 
(NIEHS) 2011] is a prospective cohort study 
of 50,884 U.S. and Puerto Rican volunteer 
women 35–74 years of age who were not 
previously diagnosed with breast cancer but 
had a full or half sister who was diagnosed 
with breast cancer. Details of the study design 
have been described elsewhere (D’Aloisio 
et al. 2010). Study enrollment occurred 
between 2003 and 2009. The Sister Study was 
approved by the Institutional Review Board 
(IRB) of the NIEHS, National Institutes of 
Health, and the Copernicus Group IRB; all 
participants provided their informed consent. 
Computer-assisted telephone interviews 
assessed demographics, medical history, and 
possible risk factors for breast cancer and other 
conditions. Participants also completed a self-
administered questionnaire on family history 
that included early-life events. Prepaid phone 
cards were given to participants to contact 
their mother or other relatives for assistance 
with completing family history questionnaires.
Our analysis included 3,534 black women 
who were 35–59 years of age when they com-
pleted baseline enrollment activities in the 
Sister Study. Similar to our previous analy-
sis, we excluded women ≥ 60 years of age 
because of temporal trends in ultrasound 
use for fibroid diagnosis and because of the 
reduced likelihood that these women had a 
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Ba c k g r o u n d: Uterine leiomyomata (fibroids) are hormonally responsive tumors, but little is known 
about risk factors. Early-life exposures may influence uterine development and subsequent response 
to hormones in adulthood. An earlier analysis of non-Hispanic white women who participated in the 
Sister Study found associations between several early-life factors and early-onset fibroids.
oBjectives: We evaluated associations of early-life and childhood exposures with early-onset 
fibroids among black women and compared the results with those found among white women.
Me t h o d s : We analyzed baseline data from 3,534 black women, 35–59 years of age, in the Sister 
Study (a nationwide cohort of women who had a sister diagnosed with breast cancer) who self-
reported information on early-life and childhood exposures. Early-onset fibroids were assessed based 
on self-report of a physician diagnosis of fibroids by the age of 30 years (n = 561). We estimated risk 
ratios (RR) and 95% confidence intervals (CI) from log-binomial regression models.
re s u l t s: Factors most strongly associated with early-onset fibroids were in utero diethylstilbestrol 
(DES; RR = 2.02; 95% CI: 1.28, 3.18), maternal pre  pregnancy diabetes or gestational diabetes (RR 
= 1.54; 95% CI: 0.95, 2.49), and monozygotic multiple birth (RR = 1.94; 95% CI: 1.26, 2.99). We 
also found positive associations with having been taller or thinner than peers at the age of 10 years 
and with early-life factors that included being the firstborn child of a teenage mother, maternal 
hypertensive disorder, preterm birth, and having been fed soy formula.
co n c l u s i o n s: With the exception of monozygotic multiple birth and maternal hypertensive dis-
order, early-life risk factors for early-onset fibroids for black women were similar to those found 
for white women. However, in contrast to whites, childhood height and weight, but not low socio-
economic status indicators, were associated with early-onset fibroids in blacks. The general consis-
tency of early-life findings for black and white women supports a possible role of early-life factors in 
fibroid development.
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living mother to ask about early-life events 
(D’Aloisio et al. 2010). A total of 3,567 black 
women, 35–59 years of age, were available at 
baseline. We excluded 10 women with miss-
ing data on fibroid status, 21 with missing age 
at fibroid diagnosis, and 2 with unlikely ages 
at fibroid diagnosis—for example, fibroids are 
rarely seen in girls < 12 years of age who have 
not begun menstruation. For comparison to 
results in black women, we updated our previ-
ously published results in non-Hispanic white 
women (n = 19,972), which were from an 
analysis done prior to completion of cohort 
enrollment (D’Aloisio et al. 2010). Data from 
27,786 non-Hispanic white women (hereafter 
referred to as “whites”) who were 35–59 years 
of age at baseline and who had complete data 
on fibroid diagnoses constituted the updated 
comparison group.
Fibroid assessment. During the base-
line telephone interview, women reported 
whether a physician or health professional 
had ever diagnosed them as having uterine 
fibroids and their age at diagnosis. Because 
fibroids are highly prevalent and because their 
prevalence increases with age until meno-
pause, many older women have undiagnosed 
fibroids. Therefore, we focused our study on 
early-onset fibroids to limit misclassification 
of women as noncases. For white women, 
we previously defined early-onset fibroids as 
a diagnosis at ≤ 35 years of age (D’Aloisio 
et al. 2010) based on ultrasound screening 
results that have shown that fibroid preva-
lence accelerates after 35 years of age (Baird 
et al. 2003; Laughlin et al. 2010). However, 
Laughlin et al. (2010) reported that the esti-
mated age at onset may be about 10 years 
earlier for black women. Because our fibroid 
diagnoses are based on self-reported data, we 
used a conservative estimate to define early-
onset fibroids in black women as a reported 
diagnosis at ≤ 30 years of age. We considered 
noncases to be all women who did not report 
early-onset fibroids, regardless of whether they 
reported a later fibroid diagnosis.
Exposure and covariate assessment. 
As previously described, most of the early-
life exposures were ascertained in self-
  administered family history questionnaires 
that were completed at baseline (D’Aloisio 
et al. 2010). Early-life exposures included 
birth weight (pounds/ounces), categorical ges-
tational age at birth, singleton or multiple 
birth, ever breastfed during infancy, ever fed 
soy formula, and maternal factors involving 
the index pregnancy (maternal age at birth, 
residence and work on a farm, smoking, DES 
use, pre  pregnancy diabetes, gestational dia-
betes, preeclampsia, and gestational hyper-
tension). Gestational diabetes was defined 
as reporting gestational diabetes during the 
index pregnancy and reporting no history 
of diabetes before the index pregnancy. We 
defined mothers as having had gestational 
hypertension during the index pregnancy 
only if pregnancy-related high blood pressure 
was reported in the absence of preeclampsia. 
To allow for uncertainty, response options 
were “definitely,” “probably,” “probably 
not,” and “definitely not” as well as “don’t 
know” for most early-life questions. However, 
“don’t know” was the only option available 
to address uncertainty for gestational age, 
birth weight, singleton or multiple birth, and 
maternal age at birth.
Questionnaires provided additional infor-
mation on multiple births including number of 
babies delivered from the index pregnancy, sex 
of multiple birth sibling(s), and zygosity based 
on the participant’s perception and test results 
when available. Using this information, we 
assigned twin births as monozygotic (report-
ing a twin sister who is genetically identical 
to the participant based on perception or test-
ing), dizygotic (reporting a twin brother or a 
twin sister who is not genetically identical to 
the participant), or unknown (missing data to 
categorize type of twin birth). For the < 1% 
of black or white participants who reported 
having two or more multiple birth siblings, 
we combined them with twin birth catego-
ries according to the following criteria: mono-
zygotic (all were genetically identical sisters), 
dizygotic (no sisters that are genetically identi-
cal to the participant), or unknown (missing 
data to categorize multiple births) or poly-
zygotic (having a genetically identical sister and 
a non–identical multiple birth sibling). Birth 
order was calculated using birthdates reported 
by participants for full siblings and half-siblings 
sharing the same mother. Participants reported 
sisters’ birthdates during the telephone inter-
view and brothers’ birthdates in the family his-
tory questionnaire. Questionnaires also asked 
how long participants were breastfed or fed 
with soy formula, and whether soy formula 
consumption occurred during the first two 
months of life. Whether the participant’s 
mother was alive at baseline was reported in 
the family history questionnaire.
Participants reported childhood expo-
sures during the baseline telephone interview. 
Childhood socio  economic factors included 
educational level of parents or guardians in the 
household when the participant was 13 years 
of age, family income level based on self-re-
ported categories (poor, low, middle, or well 
off), and food insecurity (not having enough to 
eat at times during childhood). Developmental 
factors were age at menarche and height 
and weight relative to peers at age 10 years. 
Information on participant characteristics 
at baseline, including age, education, smok-
ing status, alcohol intake, ages at live and still 
births, and menopausal status, were assessed 
during the telephone interview. Body mass 
index at baseline was calculated using home 
visit measurements of weight (pounds) and 
height (inches).
Statistical analyses. We estimated risk ratios 
(RR) with 95% confidence intervals (CI) using 
log-binomial regression for associations between 
each exposure and early-onset fibroid diagnosis. 
For infancy feeding and maternal exposures 
involving the index pregnancy (except for 
maternal age at birth), women were classified 
as exposed if they reported “definitely” or 
“probably” for a given factor and as unexposed 
if they reported “probably not” or “definitely 
not.” We did not analyze data on how long 
participants were breast-fed or fed with soy 
formula because a substantial proportion of 
participants did not know this information. For 
birth weight analyses, we created the following 
categories: < 2,500 g (low), 2,500–3,999 g, and 
≥ 4,000 g (high) based on clinical definitions 
of low and high birth weight and similarity of 
fibroid risk within categories. For maternal age 
and birth order, we created a combined index 
variable based on similarities in associations 
with fibroids and correlations between young 
maternal age at birth and being the firstborn 
using the following categories: < 20 years old 
and firstborn, ≥ 20 years old and firstborn, 
< 20 years old and not firstborn, and ≥ 20 years 
old and not firstborn.
We considered variables as confounders if 
they either influenced reporting or were asso-
ciated with the fibroid outcome and early-life 
and childhood exposures. Specifically, in all 
race-specific log-binomial regression models, 
we included participant’s age and education 
because they may affect reporting of fibroids 
and exposures, and we included the maternal 
age at birth/birth-order index variable because 
it was associated with fibroids in our data and 
influences other early-life and childhood fac-
tors. We also adjusted for childhood fam-
ily income in analyses for whites but not for 
blacks because childhood family income was 
only associated with the fibroid outcome for 
whites. Because of missing data on confound-
ers, our adjusted analyses are based on 3,201 
black women and 27,048 white women. For 
many of the observations excluded from the 
adjusted analyses, women did not complete 
family history questionnaires (n = 203 blacks; 
n = 361 whites), which resulted in missing 
data for maternal age at birth, birth order, and 
other early-life exposures. Despite evidence 
that early menarche is a risk factor for fibroids 
(Marshall et al. 1998; Wise et al. 2004), we 
did not adjust for age at menarche because it 
may be on the causal pathway between expo-
sures of interest and fibroids. In secondary 
analyses, we further addressed whether other 
early-life factors may be acting as confounders 
by reevaluating associations after restricting 
analyses to smaller subsets of women without 
the potentially related factors. For example, 
we reevaluated the association with DES after D’Aloisio et al.
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excluding maternal conditions involving the 
index pregnancy (diabetes and hypertensive 
disorder). We conducted statistical analyses 
using SAS software (version 9.2; SAS Institute 
Inc., Cary, NC).
To assess whether our primary results for 
blacks were biased due to a high proportion 
of missing data for some early-life exposures, 
we also estimated associations with early-life 
exposures after performing multiple imputation 
analyses. These analyses assumed that missing 
data were not related to the actual values of 
missing variables but may have been associated 
with values of other study variables (i.e., we 
assumed that data were missing at random). 
We obtained ten imputation data sets from 
multiple imputation by chained equations using 
IVEware (version 0.1; University of Michigan, 
Ann Arbor, MI), which fits a series of regression 
models conditional on other variables and 
imputes missing data based on the values 
predicted for each participant in these models 
(Raghunathan et al. 2001, 2009). The multiple 
imputation regression models included all early-
life factors (excluding soy formula consumption 
in the first two months of life because of 
multicollinearity with any soy formula 
consumption), childhood family income, 
participant’s age, participant’s education, 
mother’s vital status at baseline, and early-onset 
fibroid status. Childhood family income and 
maternal vital status were not confounders in 
log-binomial regression models; however, they 
were included in multiple imputation regression 
models because they influenced whether early-
life data were missing. Log-binomial regression 
analyses for associations with early-onset fibroids 
were repeated in the 10 imputation data sets as 
previously described, and regression estimates 
were combined using PROC MIANALYZE 
in SAS (version 9.2; SAS Institute Inc.). In 
secondary analyses after imputation of missing 
data, we also explored whether there was 
possible confounding among the early-life 
exposures by adjusting for additional early-
life factors in log-binomial regression models. 
Multiple imputation of missing data allowed 
for simultaneous adjustment for several early-
life factors in log-binomial regression models 
without reductions in sample size.
Results
The overall prevalence of self-reported fibroids 
among black women was 52%. Early-onset 
fibroids (diagnosed at ≤ 30 years of age) were 
reported by 16% of black women (Table 1). 
Black women who reported early-onset 
fibroids (cases) tended to be older at baseline 
(45–59 years of age, 82% vs. 79% of non-
cases) and were more likely to have received at 
least an associate’s or technical degree (74% vs. 
67%) than were women who did not report 
an early-onset diagnosis (Table 1). In addition, 
proportionally more cases (33%) than noncases 
(29%) reported no live or still births before 
31 years of age, and cases were much more 
likely than were noncases to have reported that 
menarche began at ≤ 11 years of age (33% 
vs. 24%) and that they were surgically meno-
pausal at baseline (56% vs. 33%) (Table 1). 
Furthermore, cases were three times as likely 
to have had a hysterectomy at ≤ 35 years of age 
than were noncases (26% vs. 8%), which sug-
gests that many of the cases experienced severe 
fibroid-related morbidity.
Early-life factors. Eight early-life factors 
(DES, diabetes, hypertensive disorder, being 
the firstborn child of a teenage mother, low 
birth weight, early gestational age at birth, 
multiple birth, and soy formula) were associ-
ated with at least a 20% relative increase in 
the risk of early-onset fibroid diagnosis among 
black women (Table 2). The strongest associa-
tions were with in utero DES (RR = 2.02; 95% 
CI: 1.28, 3.18) and maternal pre  pregnancy 
diabetes or gestational diabetes (RR = 1.54; 
95% CI: 0.95, 2.49). The association with ges-
tational diabetes (RR = 2.09; 95% CI: 1.00, 
4.34) was stronger than the association with 
pre  pregnancy diabetes (Table 2). Excluding 
women who reported that their mothers had 
medical conditions during the index pregnancy 
(hypertensive disorder and pre  pregnancy dia-
betes or gestational diabetes) did not affect 
the association with in utero DES (RR = 1.95; 
95% CI: 1.15, 3.30) based on 2,240 obser-
vations. In our previously published study of 
whites (D’Aloisio et al. 2010), we found that 
the association with DES was driven by 
women who reported probable rather than 
definite exposure. However, we estimated asso-
ciations separately for this analysis of black 
women who reported definite and probable 
exposure to in utero DES, and we found that 
RRs were comparable (definite, RR = 1.87; 
95% CI: 1.00, 3.50; probable, RR = 2.22; 95% 
CI: 1.15, 4.26). The multiple birth association 
appeared to be specific to monozygotic mul-
tiple births (RR = 1.94; 95% CI: 1.26, 2.99) 
(Table 2). After restricting analyses to singleton 
births and excluding women born at least 1 
month early, we observed little change in the 
association between low birth weight and early-
onset fibroids (RR = 1.27; 95% CI: 0.94, 1.71 
based on 1,833 observations). Although mater-
nal farm residence during the index pregnancy 
was associated with early-onset fibroids, we 
found this association only among women who 
reported that their mothers had not worked on 
a farm during the index pregnancy.
Childhood factors. Two factors—having 
been taller and having been thinner at age 
10 years compared with peers—were asso-
ciated with ≥ 20% increases in the RRs of 
Table 1. Baseline characteristics [n (%)] by self-reported diagnosis of early-onset uterine fibroids among 
black women, 35–59 years of age, in the Sister Study, 2003–2009 (n = 3,534).a
aCases are women with self-reported diagnosis of fibroids at ≤ 30 years of age. bLess than high school includes 3 cases 
and 35 noncases. cData were missing for 203 women because they did not complete family history questionnaires. 
dTotal number of live and still births before 31 years of age. eNatural menopause includes women who had not had 
a menstrual period in the past 12 months as long as they were not pregnant, breastfeeding, or using premenopausal 
medications that cause amenorrhea. Surgical menopause includes women whose menstrual periods had ended before 
natural menopause because they had had a hysterectomy, bilateral oophorectomy, endometrial ablation, uterine artery 
embolization, or chemotherapy.
Characteristic Cases Noncases
Total 561 2,973
Age (years)
35–44 102 (18.2) 634 (21.3)
45–59 459 (81.8) 2,339 (78.7)
Highest level of education
High school or lessb 32 (5.7) 310 (10.4)
Some college, no degree 116 (20.7) 659 (22.2)
Associate’s or technical 
degree
104 (18.5) 391 (13.2)
Bachelor’s degree 167 (29.8) 859 (28.9)
Graduate degree 142 (25.3) 753 (25.3)
Missing 0 1
Maternal living status
Alive 276 (52.9) 1,498 (53.6)
Deceased 246 (47.1) 1,296 (46.4)
Missingc 39 179
Smoking status
Current 76 (13.5) 352 (11.8)
Former 131 (23.4) 688 (23.1)
Never 354 (63.1) 1,933 (65.0)
Alcohol intake (drinks/week)
0 143 (25.6) 847 (28.6)
0.01–0.49 231 (41.3) 1,124 (37.9)
0.50–2.00 104 (18.6) 511 (17.3)
2.01–6.99 55 (9.8) 314 (10.6)
≥ 7.00 26 (4.7) 166 (5.6)
Missing 2 11
Characteristic Cases Noncases
Body mass index
< 25 77 (13.8) 514 (17.6)
25–29.9 173 (31.0) 905 (30.9)
≥ 30 308 (55.2) 1,508 (51.5)
Missing 3 46
Age at menarche (years)
< 11 88 (15.7) 292 (9.8)
11 95 (16.9) 419 (14.1)
12–13 278 (49.6) 1,574 (53.0)
14 58 (10.3) 308 (10.4)
≥ 15 42 (7.5) 376 (12.7)
Missing 0 4
Parity at age 30 yearsd
0 184 (32.9) 865 (29.2)
1 178 (31.8) 837 (28.3)
2 134 (24.0) 823 (27.8)
≥ 3 63 (11.3) 437 (14.8)
Missing 2 11
Menopausal statuse
Premenopausal 159 (28.3) 1,276 (43.0)
Natural 87 (15.5) 727 (24.5)
Surgical 315 (56.1) 965 (32.5)
Missing 0 5Uterine fibroids in black women
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early-onset fibroids among blacks (Table 3). 
Childhood socio  economic factors were not 
associated with ≥ 20% increases in the RRs of 
early-onset fibroids.
Comparisons between blacks and whites. 
Early-life and childhood exposures that were 
associated with at least a 20% relative increase 
or decrease in early-onset fibroid risk for either 
black or white women are shown in Figure 1; 
we included results that we updated from the 
previous study of white women (D’Aloisio 
et al. 2010) [see Supplemental Material, 
Tables 1 and 2 (http://dx.doi.org/10.1289/
ehp.1103620) for the estimated associations 
for all study exposures among the full cohort 
of eligible white women in the Sister Study]. 
The proportion of women who reported 
early-onset fibroids was 8% for white women 
(diagnosed at ≤ 35 years of age) versus 16% for 
black women (diagnosed at ≤ 30 years of age). 
Early-life factors associated with early-onset 
fibroids among blacks were similar to those 
among white women with the exception of 
mono  zygotic multiple birth status, which was 
only associated with early-onset fibroids among 
black women. In addition, associations with 
maternal hypertensive disorder and low birth 
weight were stronger among black women 
than among white women. For maternal 
diabetes, gestational diabetes was more strongly 
associated with early-onset fibroids than was 
pre  pregnancy diabetes among blacks, whereas 
the association was stronger for pre  pregnancy 
diabetes than gestational diabetes among 
whites (RR = 1.83; 95% CI: 1.10, 3.03 and 
RR = 1.22; 95% CI: 0.72, 2.05, respectively).
There were larger differences in associa-
tions with childhood exposures between black 
and white women. Taller height and thinner 
weight at age 10 years were associated with 
early-onset fibroids only for black women 
while associations with factors indicating low 
childhood socio  economic status were gener-
ally evident only for whites.
Imputation analyses. Data on each of 
the early-life factors except maternal age at 
birth/birth-order index and multiple birth 
status were missing for at least 10% of black 
women. We performed multiple imputations 
of missing data for nearly all early-life factors 
and repeated our analyses of associations with 
fibroids [see Supplemental Material, Table 3 
(http://dx.doi.org/10.1289/ehp.1103620)]. 
Results from multiple imputation analyses 
were generally consistent with those shown in 
Table 2. After imputation of missing data, we 
adjusted our analyses for additional early-life 
factors in log-binomial regression models to 
evaluate possible confounding. Associations 
with maternal diabetes and hypertensive dis-
order were unaffected by further adjustment 
for multiple birth status (results not shown). 
The in utero DES association was only slightly 
attenuated (RR = 1.68; 95% CI: 0.98, 2.87) 
after repeating analyses with adjustment for 
maternal conditions (diabetes and hyper-
tensive disorder) and multiple birth status, 
which are factors associated with higher risk 
pregnancy and hence a potentially increased 
likelihood that mothers were prescribed DES. 
However, the association was weakened for 
low birth weight (RR = 1.12; 95% CI: 0.85, 
1.47) but was similar for having been born at 
least 1 month early (RR = 1.35; 95% CI: 0.87, 
2.08) after inclusion of both early-life factors 
in the same model and adjustment for in utero 
DES, maternal diabetes, maternal hypertensive 
disorder, and multiple birth status.
Table 2. RRs for early-onset uterine fibroidsa in association with early-life exposures among black women, 35–59 years of age, in the Sister Study, 2003–2009.
aEarly-onset uterine fibroid status was based on self-reported diagnosis at ≤ 30 years of age (adjusted: n = 505). bEach adjusted model included the following core variables: partici-
pant’s age and education and maternal age/birth-order index. Women with missing data for core variables were excluded from all models. c”Definitely” and “probably” were combined 
as affirmative responses, and “probably not” and “definitely not” were combined as negative responses.
Exposure
Total 
(n = 3,201)b Cases (n)
Adjusted RR 
(95% CI)
Maternal pregnancy factors
Farmc
Work and residence 418 59 0.88 (0.68, 1.13)
Work only 83 13 0.99 (0.60, 1.64)
Residence only 85 22 1.48 (1.03, 2.15)
None 2,429 384 1.00
Missing 186 27
Smoking statusc
Definitely/probably 738 130 1.18 (0.98, 1.42)
Definitely not/probably not 2,161 322 1.00
Missing 302 53
DES usec
Definitely/probably 42 13 2.02 (1.28, 3.18)
Definitely not/probably not 2,352 368 1.00
Missing 807 124
Diabetesc
Any 54 13 1.54 (0.95, 2.49)
Pre  pregnancy 36 8 1.38 (0.75, 2.55)
Gestational 16 5 2.09 (1.00, 4.34)
Unknown 2 0
None 2,598 407 1.00
Missing 549 85
Hypertensive disorderc
Any 176 36 1.38 (1.01, 1.87)
Preeclampsia 62 15 1.56 (0.99, 2.44)
Gestational hypertension 82 17 1.41 (0.91, 2.17)
Unknown 32 4
None 2,046 310 1.00
Missing 979 159
Exposure
Total 
(n = 3,201)b Cases (n)
Adjusted RR 
(95% CI)
Birth and infancy factors
Maternal age at birth/birth order
< 20 years/1st 183 41 1.43 (1.08, 1.90)
≥ 20 years/1st 261 34 0.83 (0.60, 1.15)
< 20 years/2nd or later 144 21 0.97 (0.65, 1.45)
≥ 20 years/ 2nd or later 2,613 409 1.00
Birth weight (g)
< 2,500 335 67 1.31 (1.03, 1.66)
2,500–3,999 1,530 239 1.00
≥ 4,000 131 17 0.84 (0.53, 1.33)
Missing 1,205 182
Gestational age at birth
Born ≥ 1 months early 83 19 1.43 (0.94, 2.16)
Born 2–4 weeks early 61 12 1.35 (0.79, 2.31)
Not born ≥ 2 weeks early 951 155 1.00
Missing 2,106 319
Multiple birth
Any 133 29 1.42 (1.02, 1.97)
Monozygotic 43 14 1.94 (1.26, 2.99)
Dizygotic 69 10 0.98 (0.55, 1.75)
Unknown or polyzygotic 21 5
None 3,057 472 1.00
Missing 11 4
Fed breast milkc
Definitely/probably 1,438 250 1.18 (0.99, 1.40)
Definitely not/probably not 1,385 200 1.00
Missing 378 55
Fed soy formulac
Definitely/probably 96 19 1.26 (0.83, 1.89)
Definitely not/probably not 2,486 411 1.00
Missing 619 75
Fed soy formula (age ≤ 2 months)
Yes 39 9 1.48 (0.84, 2.63)
No 2,553 422 1.00
Missing 609 74D’Aloisio et al.
410  v o l u m e  120 | n u m b e r 3 | March 2012  •  Environmental Health Perspectives
Discussion
We found that black women had an increased 
risk of early-onset fibroids in association with 
several early-life factors. Many of these asso-
ciations were also found among white women 
with the exception of maternal hypertensive 
disorder and monozygotic multiple birth sta-
tus. For black women, we also found that 
early-onset fibroids were associated with taller 
height and thinner weight at 10 years of age 
compared with peers, but no associations 
were observed with indicators of low socio-
economic status during childhood.
Misclassification of self-reported fibroids is 
a potential bias because fibroid risk increases 
with age, and many women who develop 
fibroids may never be diagnosed by a physi-
cian (Laughlin et al. 2010). Therefore, we only 
considered early-onset diagnoses to improve 
sensitivity by reducing misclassification in the 
noncase group. For whites, we had defined 
  early-onset cases as those occurring at ≤ 35 years 
of age (D’Aloisio et al. 2010); however, fibroids 
develop at an earlier age in blacks (Laughlin 
et al. 2010). Therefore, to reduce misclassifica-
tion in the noncase group to the same degree 
in black women, we defined early-onset cases as 
those occurring at ≤ 30 years of age. We found 
that the estimated proportion of black women 
with early-onset fibroids in our study (16%) 
was consistent with the proportion of middle-
aged black women (19%) with self-reported 
fibroids by age 30 years in the NIEHS Uterine 
Fibroid Study (Baird DD, unpublished data). 
In addition, cases were much more likely than 
noncases to report surgical menopause and 
early hysterectomies, which are expected con-
sequences for women with fibroids, and this 
supports that the specificity of self-reported 
early-onset fibroids is likely to be very high in 
our study.
Given that the majority of exposures 
occurred in utero or during infancy, exposure 
misclassification is another potential source of 
bias. However, participants received prepaid 
phone cards to encourage them to contact 
their mothers or other relatives to ask about 
early-life events, and we excluded women 
> 59 years of age who were less likely to have 
living relatives to consult. In addition, response 
categories for most of the early-life exposures 
allowed for additional uncertainty in reporting 
with definite and probable categories. We 
repeated the analyses by evaluating associations 
separately for the reporting of definite and 
probable exposure, and we did not find that the 
reported associations with DES or any of the 
other early-life factors were unduly influenced 
by reporting probable exposure (results not 
shown). It is unlikely that differential exposure 
misclassification as a result of recall bias would 
have occurred in our study because none of 
the exposures are established risk factors for 
fibroids. Instead, any exposure misclassification 
in our study would likely be nondifferential, 
which would generally result in RR estimates 
biased toward the null.
Strengths of this study include a focus on 
black women who have been shown to have 
greater fibroid incidence and morbidity than 
do white women (Baird et al. 2003; Faerstein 
et al. 2001; Kjerulff et al. 1996; Marshall et al. 
1997; Wise et al. 2005b). Despite the small 
numbers of exposed cases for many of the 
early-life exposures, we were able to replicate 
many of the early-life findings from our previ-
ous analysis of white women with the excep-
tion of unique associations with monozygotic 
multiple birth status and maternal hyperten-
sive disorder in black women. However, we 
found larger differences between blacks and 
whites in associations with childhood factors 
(D’Aloisio et al. 2010). Although > 10% of 
black women had missing data for most of 
the early-life exposures, results of multiple 
imputation analyses suggest that missing data 
did not bias reported associations.
In utero DES was one of the early-life 
exposures that was most strongly associated 
with early-onset fibroids among black women. 
Furthermore, the association between in utero 
DES and early-onset fibroids remained 
after excluding women who reported that 
mothers had medical conditions (diabetes 
and hypertensive disorder) during the index 
pregnancy, which may have increased the 
likelihood of treatment with DES. Therefore, 
these conditions were unlikely to have con-
founded the association with DES. Evidence 
from animal studies shows that DES exposure 
during early development can increase fibroid 
incidence in adulthood (Cook et al. 2007). 
Previous epidemiological studies of in utero 
DES and fibroids have reported inconsistent 
findings, possibly due to differences in study 
design and assessment of DES exposure and 
fibroids (Baird and Newbold 2005; Missmer 
et al. 2004; Wise et al. 2005a). In particular, 
Wise et al. (2005a) found no association 
between medically documented DES exposure 
and surgical fibroid cases in a prospective study 
of women from two cohorts. Using data from 
a prospective study of endometriosis in Nurses’ 
Health Study participants with intact uteri, 
Missmer et al. (2004) noted that there was no 
association between self-reported DES exposure 
and uterine fibroids. However, Baird and 
Newbold (2005) indicated a positive association 
with self-reported DES exposure based on 
small numbers of exposed cases among black 
and white women from the NIEHS Uterine 
Fibroid Study, which used ultrasound screening 
to identify fibroids and included black women 
in about 60% of the study sample. In addition, 
our finding for black women was similar to that 
for white women in the Sister Study. However, 
it is possible that women in the Sister Study 
who reported DES exposure may have received 
more gynecologic screenings, which could 
have led to a greater likelihood of detecting 
early-onset fibroids. Further studies of DES 
are needed in different study populations to 
support involvement in fibroid pathogenesis.
Another in utero factor associated with 
fibroids in black women was maternal 
diabetes—this association was slightly stronger 
Table 3. RRs for early-onset uterine fibroidsa in association with childhood socioeconomic and develop-
mental factors among blacks, 35–59 years of age, in the Sister Study, 2003–2009.
Exposure
Total 
(n = 3,201)b Cases (n)
Adjusted RR 
(95% CI)
Maximum household education (participant age 13 years)
< High school 1,050 160 0.94 (0.79, 1.12)
≥ High school  2,089 335 1.00
Missing 62 10
Family income
Poor 557 90 1.02 (0.82, 1.28)
Low 1,134 181 1.01 (0.84, 1.21)
Middle/well off 1,499 232 1.00
Missing 11 2
Not enough to eat
Yes 572 101 1.15 (0.94, 1.40)
No 2,623 404 1.00
Missing 6 0
Height relative to peers (age 10 years)
Taller 832 154 1.24 (1.03, 1.50)
Same 1,419 212 1.00
Shorter 942 139 0.99 (0.82, 1.21)
Missing 8 0
Weight relative to peers (age 10 years)
Heavier 538 83 1.09 (0.86, 1.38)
Same 1,343 190 1.00
Thinner 1,304 231 1.23 (1.03, 1.46)
Missing 16 1
aEarly-onset uterine fibroid status was based on self-reported diagnosis at ≤ 30 years of age (adjusted: n = 505). bEach 
adjusted model included the following core variables: participant’s age and education and maternal age/birth-order 
index. Women with missing data for core variables were excluded from all models.Uterine fibroids in black women
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for gestational diabetes than for pre  pregnancy 
diabetes. However, associations for gestational 
and pre  pregnancy diabetes were more similar 
in analyses after multiple imputation of missing 
data. Among whites, we also found a similar 
association with maternal diabetes, although 
the association was strongest for pre  pregnancy 
diabetes. We did not have information on 
the status of post-pregnancy diabetes in the 
participants’ mothers, and distinguishing 
gestational diabetes from young onset of 
type 2 diabetes is difficult because limited 
access to care may have influenced whether 
mothers received a diagnosis of diabetes before 
pregnancy. If black women had poorer access 
to care than did white women, this may explain 
the differences in results for the two groups. As 
previously discussed, biological support exists 
for in utero exposure to diabetes influencing 
later risk of fibroids via developmental changes 
that may affect epigenetic patterns in areas 
pertaining to regulation of relevant genes for 
fibroid pathogenesis (D’Aloisio et al. 2010). 
There were few cases of maternal diabetes 
among black women in the cohort possibly 
reflecting limitations in available medical 
care for participants’ mothers. In the United 
States, blacks have greater rates of type 2 
and gestational diabetes than do whites 
(Egede and Dagogo-Jack 2005; Savitz et al. 
2008); therefore, blacks are more likely to 
have in utero exposure to hyper  insulinemia 
and hyper  glycemia that result in adverse 
developmental consequences. Thus, in utero 
exposure to maternal diabetes may contribute 
to the elevated fibroid burden among U.S. 
black women.
We previously reported an associa-
tion between soy formula and early-onset 
fibroids among whites (D’Aloisio et al. 2010). 
Associations with having been fed soy for-
mula (ever fed soy formula and fed soy for-
mula within the first 2 months of life) were of 
similar magnitude for blacks and for whites, 
although the estimates for blacks were more 
imprecise. As previously discussed, soy formula 
might influence later risk of fibroids because 
of the high concentration of estrogenic isofla-
vones (D’Aloisio et al. 2010). This hypothesis 
is further supported by effects on the reproduc-
tive system observed in neonatal laboratory 
rodents administered genistein, the hormonally 
activated form of the isoflavone predominantly 
found in soy formula (Jefferson and Williams 
2011). There have been few studies of soy for-
mula in relation to reproductive consequences 
in humans. However, one study reported that 
having been fed soy formula was associated 
with longer menstrual bleeding and greater 
pain with menstruation (Strom et al. 2001), 
both of which are also symptoms of fibroids.
Our study of black women is the first to 
report a strong association between early-onset 
fibroid risk and multiple birth, specifically for 
having been part of a monozygotic multiple 
birth. A possible causal mechanism is unclear 
but may be due to a greater likelihood of fetal 
growth restriction and resulting metabolic 
consequences in multiple births versus single-
ton births. More than half of monozygotic 
multiple births are monochorionic, which 
may lead to a greater risk of adverse outcomes 
than for dizygotic multiple births (Vaag and 
Poulsen 2007). We also found an associa-
tion with maternal hypertensive disorder that 
persisted after accounting for multiple birth 
status. Preeclampsia and gestational hyper-
tension are more likely to occur in the U.S. 
black population than in whites (Tanaka et al. 
2007). Maternal hypertensive disorder may 
affect placental development leading to fetal 
malnourishment, which has been associated 
with increased risk of metabolic diseases in 
adulthood (Anderson 2007). Among black 
women, there were associations with early ges-
tational age at birth and with low birth weight, 
which remained after excluding multiple births 
and those born at least one month before their 
due date. However, approximately 40% of 
women were missing birth weight data, and 
> 60% were missing data on gestational age at 
birth; adjusting for other early-life confound-
ers in multiple imputation analyses resulted in 
attenuation of the association with low birth 
weight, although an association remained with 
having been born at least 1 month early. An 
association with having been born preterm 
was also found among white women, but the 
RR estimate for whites was more precise than 
for blacks. We previously discussed the pos-
sible biological plausibility for an association 
with having been born preterm based on not 
receiving enough estrogen for adequate uterine 
development (D’Aloisio et al. 2010).
With the possible exception of having a 
teenage mother, we did not find associations 
between fibroids and indicators of low socio-
economic status during childhood among 
black women, as we did for whites. Low child-
hood socio  economic status indicators such 
Figure 1. Comparisons in associations [RR (95% CI)] of selected early-life and childhood exposures with 
early-onset fibroids between black and white women, 35–59 years of age, in the Sister Study, 2003–2009.
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as parent education and self-reported family 
income level may have a different societal con-
text for blacks and whites, which may differen-
tially influence adult health outcomes (Shavers 
2007). Nevertheless, it is also possible that 
other sources of stress such as perceived racism 
(Wise et al. 2007) may have more relevance in 
fibroid pathogenesis for black women.
We also found associations with self-
reported indicators of childhood height and 
weight among blacks but not among whites. 
Specifically, we found early-onset fibroid asso-
ciations with having been taller than peers at 
age 10 years and having been thinner than 
peers at age 10 years. These associations did not 
change after including both these variables in 
the same model (results not shown), which sug-
gests that these are independent associations. 
Even though early menarche is a risk factor 
for fibroids (Marshall et al. 1998; Wise et al. 
2004), it may be on the causal pathway because 
of its relations with greater childhood body 
fat (Ahmed et al. 2009) and taller childhood 
height (Freedman et al. 2002). Nevertheless, 
we verified that further adjustment for age 
at menarche did not affect our findings with 
childhood weight and height (results not 
shown). We also further excluded women 
who reported low birth weight (because size 
at birth may influence later childhood weight) 
and found that the association with thinner 
childhood weight did not change (result not 
shown). However, we acknowledge that self-
reporting by adults of childhood height and 
weight relative to peers has limitations in that 
they are not absolute measures of height or 
weight and reflect participants’ perceptions 
of their size relative to peers as well as their 
peer group. Terry et al. (2007) reported no 
association with childhood body fatness using 
data from the Nurses’ Health Study, which is 
consistent with our findings in whites.
Conclusions
Our findings in blacks replicate many of our 
previously published associations with early-
life factors and fibroids in whites (D’Aloisio 
et al. 2010). Biologically plausible mecha-
nisms exist for these factors to promote fibroid 
pathogenesis in adulthood. Despite largely 
consistent findings between blacks and whites, 
most of these early-life factors have not been 
investigated in other study populations, so 
further replication is needed to support their 
possible involvement in fibroid pathogenesis. 
Although many exposures such as diabetes and 
pregnancy complications were relatively rare 
in our cohort, their prevalence in the general 
population is likely growing given the obesity 
epidemic in the United States.
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